Differential Analysis of Histopathological and Genetic Markers of Cancer Aggressiveness, and Survival Difference in EBV-Positive and EBV-Negative Prostate Carcinoma

0
21
Scientists used previously characterized Epstein-Barr virus (EBV)-PCR-positive and EBV-negative prostate carcinoma (PCa) tissues to perform an IHC-based assessment of key histopathological and molecular markers of PCa aggressiveness
[Scientific Reports]
Full Article